Crocs, Inc. Honored with American Podiatric Medical Association's Highest Award
March 27 2008 - 9:51AM
Business Wire
Crocs, Inc. (NASDAQ: CROX) was recently honored with the Executive
Director�s Award from the American Podiatric Medical Association
(APMA). The award recognizes CrocsRX�, a leader in medical shoe
sales, as making a significant contribution to the advancement of
podiatric medicine in 2007. The award will be presented at the
APMA�s Annual House of Delegates Meeting in Washington, DC on April
7, 2008. �The APMA is the leading voice in podiatric medical care,
so it is a huge honor to receive their highest award,� said Eddie
Scott, Director of CrocsRX�. �We look forward to continuing to work
with APMA to offer ergonomic footwear and bringing those solutions
to market for consumers.� �The APMA is committed to improving the
quality of life for individuals suffering from a variety of
health-related ailments through podiatric solutions,� said Dr.
Glenn Gastwirth, Executive Director of the APMA. �We are pleased to
recognize CrocsRX� for advancing footwear alternatives for these
patients while offering fashionable designs that protect while
relieving pain.� A specialty footwear line designed for people with
specific medical and therapeutic, podiatric conditions, the entire
CrocsRX� product line has received the APMA Seal of Acceptance
based on a myriad of podiatric standards. Included in the CrocsRX�
line are three distinctive styles � the Relief (MSRP: $39.99),
Cloud (MSRP: $39.99) and Silver Cloud (MSRP: $49.99). All three
styles combine specialized features to reduce foot discomfort,
including Crocs� proprietary Croslite� material which conforms to
the foot to create a truly customized fit. To learn more about
CrocsRX� footwear, or join the more than 3,000 doctors that either
recommend shoes from the CrocsRX� line to their patients or
distribute CrocsRX� models directly through their offices, visit
www.crocsrx.com. About Crocs, Inc: Crocs, Inc. is a rapidly growing
designer, manufacturer and retailer of footwear for men, women and
children under the Crocs� brand. All Crocs� brand shoes feature
Crocs� proprietary closed-cell resin, Croslite�, which represents a
substantial innovation in footwear. The Croslite� material enables
us to produce soft, comfortable, lightweight, superior-gripping,
non-marking and odor-resistant shoes. These unique elements make
Crocs� footwear ideal for casual wear, as well as for professional
and recreational uses such as boating, hiking, hospitality and
gardening. The versatile use of the material has enabled Crocs to
successfully market our products to a broad range of consumers.
Crocs� shoes are sold in more than 90 countries and come in a wide
array of colors and styles. Please visit www.crocs.com for
additional information. About the American Podiatric Medical
Association: Founded in 1912, the American Podiatric Medical
Association represents the nation�s premier foot and ankle
physicians. The Association has component societies in 53 locations
in the U.S. and its territories and a membership of close to 11,500
doctors of podiatric medicine. For free foot health information,
contact APMA at 1-800-FOOTCARE (1-800-366-8227) or visit
www.apma.org on the Web.
Crocs (NASDAQ:CROX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Crocs (NASDAQ:CROX)
Historical Stock Chart
From Jul 2023 to Jul 2024